Stay updated on Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page.

Latest updates to the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1.0%
- Check27 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check64 days agoChange DetectedThe webpage has been updated to include new information about a clinical trial for Recurrent Plasma Cell Myeloma, including details about collaborators and registry identifiers, while significant content regarding the trial's objectives and methodology has been removed.SummaryDifference40%
Stay in the know with updates to Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page.